← Evidence library

BIB_322

Ribas A et al. (UCLA + multicentre). AMBER cohorts 1c/1e/2A: Combined PD-1 and TIM-3 targeting (cobolimab + dostarlimab) in locally advanced or metastatic melanoma. Clin Cancer Res August 14 2025. [Tasks: 17, 18, 19b] Tier: 2 (phase 1/2) Grade: B Retrieved: 2026-05-15

Evidence grade

B

Tier

2 (phase 1/2)

Cited by tasks

17, 18, 19b

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_322/findings.md (research corpus). This page is a short context summary — not individualised medical advice.